Steven Cohen’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-805,644
Closed -$33.2M 2557
2024
Q3
$33.2M Sell
805,644
-675,639
-46% -$32.4M 0.08% 277
2024
Q2
$71.3M Buy
1,481,283
+786,691
+113% +$34.9M 0.19% 147
2024
Q1
$33.3M Buy
694,592
+26,163
+4% +$1.4M 0.08% 302
2023
Q4
$43.4M Buy
668,429
+432,525
+183% +$26M 0.1% 250
2023
Q3
$15.4M Sell
235,904
-445,196
-65% -$28M 0.05% 483
2023
Q2
$39.6M Sell
681,100
-2,005,796
-75% -$127M 0.12% 212
2023
Q1
$166M Buy
+2,686,896
New +$161M 0.51% 29
2022
Q2
Sell
-345,600
Closed -$31.3M 1696
2022
Q1
$31.3M Sell
345,600
-101,900
-23% -$8.34M 0.12% 220
2021
Q4
$40.8M Buy
447,500
+352,100
+369% +$30.2M 0.16% 167
2021
Q3
$7.74M Sell
95,400
-48,623
-34% -$4.09M 0.03% 545
2021
Q2
$13.4M Buy
+144,023
New +$14M 0.06% 379
2021
Q1
Sell
-436,851
Closed -$38.1M 1218
2020
Q4
$38.1M Buy
436,851
+296,298
+211% +$20.9M 0.19% 143
2020
Q3
$9.7M Buy
+140,553
New +$9.04M 0.05% 419

Other funds holding NARI

Steven Cohen's NARI Position: Q4 2024 in Review

Steven Cohen sold out of Inari Medical, Inc. Common Stock (NARI) in Q4 2024, closing a stake of 805,644 shares — an estimated $33.2M sold.

Steven Cohen first reported a position in NARI in Q3 2020 and held it in 13 quarters. The position peaked at $166M in Q1 2023. 258 funds tracked by Wall St. Rank hold NARI as of Q4 2024.

  • Steven Cohen reported no remaining Inari Medical, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Steven Cohen sold 805,644 Inari Medical, Inc. Common Stock shares in Q4 2024, an estimated $33.2M.
  • Steven Cohen first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • Steven Cohen's Inari Medical, Inc. Common Stock position peaked at $166M in Q1 2023.
  • 258 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2024.

Based on Point72 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.